Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine in HBeAg Negative Chronic Hepatitis B in Iran
NCT00354653Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Feb 2002
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine in Chronic Hepatitis B (CHB), sponsored by ViiV Healthcare. Started Feb 2002; status: completed.
02
Drugs
lamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00354653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354653.